On the fly News and insights, exclusive to thefly.com

M

Macy's

$19.38 /

+0.11 (+0.57%)

, REAL

RealReal

$16.96 /

-0.85 (-4.77%)

09:04
08/14/19
08/14
09:04
08/14/19
09:04

Fly Intel: Pre-market Movers

UP AFTER EARNINGS: Purple (PRPL), up 19%... RealReal (REAL), up 10%. ALSO HIGHER: Presidio (PSDO), up 21% after entering into a definitive agreement to be acquired by funds advised by BC Partners in an all-cash transaction valued at approximately $2.1B, including Presidio's net debt.... Endeavor Silver (EXK), up 3% after reporting results from its ongoing exploration program on the Parral project in Chihuahua, Mexico. DOWN AFTER EARNINGS: Macy's (M), down 16%... Canada Goose (GOOS), down 3%... Luckin Coffee (LK), down 8%... Myriad genetics (MYGN), down 33%... Tilray (TLRY), down 12%. ALSO LOWER: Acorda Therapeutics (ACOR), down 4% after H.C. Wainwright analyst Raghuram Selvaraju downgraded the stock to Neutral from Buy and lowered his price target for the shares to $6 from $31. The "anemic" sales trajectory for Inbrija is concerning, particularly in light of the $323.8M in convertible notes maturing June 15, 2021, Selvaraju tells investors.

M

Macy's

$19.38 /

+0.11 (+0.57%)

REAL

RealReal

$16.96 /

-0.85 (-4.77%)

PRPL

Purple Innovation

$6.53 /

+0.1 (+1.56%)

TLRY

Tilray

$46.05 /

+3.58 (+8.43%)

GOOS

Canada Goose

$43.21 /

+1.12 (+2.66%)

LK

Luckin Coffee

$24.61 /

+0.06 (+0.24%)

PSDO

Presidio

$13.19 /

+0.1 (+0.76%)

EXK

Endeavour Silver

$2.47 /

-0.195 (-7.33%)

MYGN

Myriad Genetics

$44.62 /

-0.63 (-1.39%)

ACOR

Acorda Therapeutics

$2.72 /

-0.11 (-3.89%)

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 18

    Sep

  • 19

    Sep

  • 13

    Nov

M Macy's
$19.38 /

+0.11 (+0.57%)

07/23/19 Jefferies
Wayfair well positioned to take wedding registry market share, says Jefferies
05/16/19
Fly Intel: Top five analyst upgrades
05/16/19 Morgan Stanley
Macy's EPS beat masks 'worrying' core retail performance, says Morgan Stanley
05/16/19 Goldman Sachs
Macy's upgraded to Neutral from Sell at Goldman Sachs
REAL RealReal
$16.96 /

-0.85 (-4.77%)

08/12/19 Credit Suisse
RealReal near-term visibility more limited, says Credit Suisse
07/23/19 BofA
RealReal initiated with a Neutral at BofA/Merrill
07/23/19 Cowen
RealReal initiated with an Outperform at Cowen
07/23/19 KeyBanc
RealReal initiated with an Overweight at KeyBanc
PRPL Purple Innovation
$6.53 /

+0.1 (+1.56%)

09/19/18 Wedbush
Antidumping petition could lead to relief for mattress cos, says Wedbush
TLRY Tilray
$46.05 /

+3.58 (+8.43%)

08/14/19 Benchmark
Tilray price target lowered to $80 from $200 at Benchmark
08/14/19 Stifel
Stifel keeps Hold rating, $38 price target on Tilray after Q2 report
07/17/19 Ladenburg
Tilray initiated with a Neutral at Ladenburg
06/28/19 Consumer Edge
Tilray initiated with an Overweight at Consumer Edge
GOOS Canada Goose
$43.21 /

+1.12 (+2.66%)

05/31/19
Fly Intel: Top five analyst upgrades
05/31/19 Goldman Sachs
Goldman upgrades Canada Goose to Buy, says stock 'compelling' after selloff
05/31/19 Goldman Sachs
Canada Goose upgraded to Buy from Neutral at Goldman Sachs
05/30/19
Fly Intel: Top five analyst downgrades
LK Luckin Coffee
$24.61 /

+0.06 (+0.24%)

06/12/19 CICC
Luckin Coffee initiated with a Buy at CICC
06/12/19 Citi
Citi survey shows little impact to Starbucks in China from trade war
06/11/19 Credit Suisse
Luckin Coffee initiated with an Outperform at Credit Suisse
06/11/19 Morgan Stanley
Luckin Coffee initiated with an Equal Weight at Morgan Stanley
PSDO Presidio
$13.19 /

+0.1 (+0.76%)

06/06/19 Evercore ISI
Presidio started with an In Line at Evercore ISI
12/04/18
On The Fly: Top five analyst initiations
12/04/18 Truist
Presidio initiated with a Buy at SunTrust
12/04/18 Truist
Presidio initiated with a Buy at SunTrust
EXK Endeavour Silver
$2.47 /

-0.195 (-7.33%)

05/07/19 Noble Capital
Endeavour Silver downgraded to Market Perform from Outperform at Noble Capital
01/14/19 Noble Capital
Endeavour Silver upgraded to Outperform from Market Perform at Noble Financial
12/11/18 Roth Capital
Endeavour Silver initiated with a Buy at Roth Capital
11/01/18 Noble Capital
Endeavour Silver downgraded to Market Perform from Outperform at Noble Financial
MYGN Myriad Genetics
$44.62 /

-0.63 (-1.39%)

08/14/19 JPMorgan
Myriad Genetics reported another disappointing quarter, says JPMorgan
08/14/19 Deutsche Bank
Myriad Genetics price target lowered to $35 from $45 at Deutsche Bank
08/14/19 Piper Sandler
Myriad Genetics downgraded to Neutral from Overweight at Piper Jaffray
08/02/19 BofA
BofA/Merrill upgrades Myriad to Neutral on unexpected UnitedHealthcare decision
ACOR Acorda Therapeutics
$2.72 /

-0.11 (-3.89%)

08/14/19 H.C. Wainwright
Acorda Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
08/02/19 Cantor Fitzgerald
Acorda Therapeutics price target lowered to $12 from $20 at Cantor Fitzgerald
05/23/19
Acorda Therapeutics initiated with a Neutral at Wedbush
05/22/19 Wedbush
Acorda Therapeutics initiated with a Neutral at Wedbush

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.